Work

Advancing the Management of CH, MDS, and AML From the First Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Conference

Year: 2025

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2025.03.005

Authors: Hetty E. Carraway, Andrew M. Brunner, Catherine E. Lai, Marlise R. Luskin, Jae Park, Alexander E. Perl, Eytan M. Stein, Eunice S. Wang, Amer M. Zeidan, Joshua F. Zeidner, Rami Komrokji

Institutions: Cleveland Clinic, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Harvard University, Massachusetts General Hospital, Abramson Cancer Center, University of Pennsylvania, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Roswell Park Comprehensive Cancer Center, Yale University, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Moffitt Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Eli Lilly and Company, AstraZeneca, Cleveland Clinic, Life Sciences, University of California, Los Angeles

OpenAlex ID: W4408416728

FWCI: 0.636

Cites: 38

Cited by: 1

Related to: 10